> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Apotex Recalls Contraceptive Due to Packaging Error
- URL: https://www.fdaweb.com/apotex-recalls-contraceptive-due-to-packaging-error/
- Published: 2019-03-05T12:00:00.000Z
- Updated: 2026-09-15T01:10:07.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5143524

Apotex has recalled four lots of drospirenone and ethinyl estradiol tablets because the contraceptive may contain defective blisters with incorrect tablet arrangements or an empty blister pocket. The affected product is manufactured by Oman Pharmaceutical Products Co.  
  
According to a [recall notice](https://www.fda.gov/Safety/Recalls/ucm632629.htm?ref=fdaweb.com), the packaging error could cause a patient to miss a tablet or that a patient takes a placebo instead of an active tablet. Such errors could cause loss of efficacy, it says. To date, no case has been reported for pregnancy or an adverse event related to the packaging error.